Localized Prostate Cancer Clinical Trial
Official title:
Evaluation of an Alternative Treatment of Localized Prostate Cancer by Guided MRI Transurtral Ultrasound With 1-year Control of the Absence of Cancer
Primary purpose : Evaluation of the efficiency and safety of an alternative global prostate treatment in localized prostate cancer. Primary Objective: Absence of clinically significant cancer (CSC) on control biopsy at 1-year follow-up. Secondary Objectives: 1. Biochemical response 2. Presence of any CSC on biopsy at 1- and 2-year follow-up 3. Radical treatment free survival 4. Adverse events, clinical tolerance 5. Urinary continence 6. Erectile function 7. Quality of life
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT02159690 -
A Phase II Neoadjuvant Study of Enzalutamide, Abiraterone Acetate, Dutasteride and Degarelix in Men With Localized Prostate Cancer Pre-prostatectomy
|
Phase 2 | |
| Completed |
NCT00196781 -
Treatment Decision Making in Early-Stage Prostate Cancer
|
Phase 3 | |
| Recruiting |
NCT03821246 -
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
|
Phase 2 | |
| Active, not recruiting |
NCT03814252 -
Prospective Clinical Safety and Efficacy Study of Lesion-targeted MRI-TULSA for Localized Prostate Cancer
|
N/A | |
| Completed |
NCT01931046 -
Use of Recombinant Adenovirus Therapy to Treat Localized Prostate Cancer
|
Phase 1/Phase 2 | |
| Completed |
NCT01714219 -
Effect of New Posterior Reconstruction Method on Recovery of Continence After Robot-assisted Laparoscopic Prostatectomy
|
N/A | |
| Active, not recruiting |
NCT03315754 -
Study of the Efficacy, Safety and Quality of Life After TOOKAD® Soluble (VTP) for Intermediate Risk Prostate Cancer.
|
Phase 2 | |
| Recruiting |
NCT05010343 -
Functional Image-Guided Carbon Ion Irradiation With Simultaneous Integrated Boost for Prostate Cancer
|
Phase 2 | |
| Recruiting |
NCT06325995 -
Hypofractionated Post-prostatectomy Radiotherapy (HYPORT)for Localized Prostate Cancer
|
N/A | |
| Recruiting |
NCT06051942 -
PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs
|
N/A | |
| Completed |
NCT02297386 -
[18F] Dihydro-testosterone Pet and MR Imaging In Patients With Localized Prostate Cancer
|
Phase 1 | |
| Not yet recruiting |
NCT06117059 -
The PRECISION Study: 3 Fractions of Prostate SBRT and RayPilot HypoCath Image Guidance
|
N/A | |
| Withdrawn |
NCT04225299 -
Evaluation of Efficacy of TOOKAD® (VTP) Versus Active Surveillance for Intermediate Risk Localized Prostate Cancer
|
Phase 3 | |
| Recruiting |
NCT06054867 -
PRCT002 PRostate Cancer Treatment With the AQUABEAM Robotic System
|
N/A | |
| Active, not recruiting |
NCT02435472 -
Active Surveillance Exercise Clinical Trial
|
N/A | |
| Completed |
NCT00717613 -
Psychosocial and Patient Education Needs of Prostate Cancer Patients Selecting Watchful Waiting
|
N/A | |
| Completed |
NCT02662673 -
Evaluation of Focal Treatments of Localized Prostate Cancers With High Intensity Focused Ultrasound Using the Focal One® Device
|
N/A | |
| Recruiting |
NCT05155046 -
18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy
|
Phase 2 | |
| Completed |
NCT01902680 -
Phase II Study of Feasibility of Focal Therapy for Prostate Cancer of Good Prognosis With Permanent I125 Localized Implant.
|
Phase 2 | |
| Recruiting |
NCT00651417 -
Use of Organic Germanium or Placebo for the Prevention of Radiation Induced Fatigue
|
Phase 2 |